Hepatocellular uptake of cyclodextrin-complexed curcumin during liver preservation

A feasibility study

Saber Abdelkader Saidi, Nicolas Meurisse, Ina Jochmans, Veerle Heedfeld, Tine Wylin, Jaakko Parkkinen, Jacques Pirenne, Diethard Monbaliu, Abdelfattah El Feki, Jos van Pelt

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalBiopharmaceutics & Drug Disposition
Volume39
Issue number1
Pages (from-to)18-29
Number of pages12
ISSN0142-2782
DOIs
Publication statusPublished - Jan 2018
MoE publication typeA1 Journal article-refereed

Fields of Science

  • 3111 Biomedicine
  • curcumin
  • ischemia reperfusion injury
  • liver preservation
  • oxidative stress
  • ISCHEMIA-REPERFUSION INJURY
  • SOLID LIPID NANOPARTICLES
  • SEE VOL. 102
  • ISCHEMIA/REPERFUSION INJURY
  • ANTIINFLAMMATORY AGENTS
  • CELLULAR UPTAKE
  • WARM ISCHEMIA
  • DEATH DONORS
  • BRAIN-DEATH
  • TRANSPLANTATION

Cite this

Saidi, S. A., Meurisse, N., Jochmans, I., Heedfeld, V., Wylin, T., Parkkinen, J., ... van Pelt, J. (2018). Hepatocellular uptake of cyclodextrin-complexed curcumin during liver preservation: A feasibility study. Biopharmaceutics & Drug Disposition, 39(1), 18-29. https://doi.org/10.1002/bdd.2108
Saidi, Saber Abdelkader ; Meurisse, Nicolas ; Jochmans, Ina ; Heedfeld, Veerle ; Wylin, Tine ; Parkkinen, Jaakko ; Pirenne, Jacques ; Monbaliu, Diethard ; El Feki, Abdelfattah ; van Pelt, Jos. / Hepatocellular uptake of cyclodextrin-complexed curcumin during liver preservation : A feasibility study. In: Biopharmaceutics & Drug Disposition. 2018 ; Vol. 39, No. 1. pp. 18-29.
@article{1a46b47daad64aa6913d1bf92f63723e,
title = "Hepatocellular uptake of cyclodextrin-complexed curcumin during liver preservation: A feasibility study",
keywords = "3111 Biomedicine, curcumin, ischemia reperfusion injury, liver preservation, oxidative stress, ISCHEMIA-REPERFUSION INJURY, SOLID LIPID NANOPARTICLES, SEE VOL. 102, ISCHEMIA/REPERFUSION INJURY, ANTIINFLAMMATORY AGENTS, CELLULAR UPTAKE, WARM ISCHEMIA, DEATH DONORS, BRAIN-DEATH, TRANSPLANTATION",
author = "Saidi, {Saber Abdelkader} and Nicolas Meurisse and Ina Jochmans and Veerle Heedfeld and Tine Wylin and Jaakko Parkkinen and Jacques Pirenne and Diethard Monbaliu and {El Feki}, Abdelfattah and {van Pelt}, Jos",
year = "2018",
month = "1",
doi = "10.1002/bdd.2108",
language = "English",
volume = "39",
pages = "18--29",
journal = "Biopharmaceutics & Drug Disposition",
issn = "0142-2782",
publisher = "Wiley",
number = "1",

}

Saidi, SA, Meurisse, N, Jochmans, I, Heedfeld, V, Wylin, T, Parkkinen, J, Pirenne, J, Monbaliu, D, El Feki, A & van Pelt, J 2018, 'Hepatocellular uptake of cyclodextrin-complexed curcumin during liver preservation: A feasibility study', Biopharmaceutics & Drug Disposition, vol. 39, no. 1, pp. 18-29. https://doi.org/10.1002/bdd.2108

Hepatocellular uptake of cyclodextrin-complexed curcumin during liver preservation : A feasibility study. / Saidi, Saber Abdelkader; Meurisse, Nicolas; Jochmans, Ina; Heedfeld, Veerle; Wylin, Tine; Parkkinen, Jaakko; Pirenne, Jacques; Monbaliu, Diethard; El Feki, Abdelfattah; van Pelt, Jos.

In: Biopharmaceutics & Drug Disposition, Vol. 39, No. 1, 01.2018, p. 18-29.

Research output: Contribution to journalArticleScientificpeer-review

TY - JOUR

T1 - Hepatocellular uptake of cyclodextrin-complexed curcumin during liver preservation

T2 - A feasibility study

AU - Saidi, Saber Abdelkader

AU - Meurisse, Nicolas

AU - Jochmans, Ina

AU - Heedfeld, Veerle

AU - Wylin, Tine

AU - Parkkinen, Jaakko

AU - Pirenne, Jacques

AU - Monbaliu, Diethard

AU - El Feki, Abdelfattah

AU - van Pelt, Jos

PY - 2018/1

Y1 - 2018/1

KW - 3111 Biomedicine

KW - curcumin

KW - ischemia reperfusion injury

KW - liver preservation

KW - oxidative stress

KW - ISCHEMIA-REPERFUSION INJURY

KW - SOLID LIPID NANOPARTICLES

KW - SEE VOL. 102

KW - ISCHEMIA/REPERFUSION INJURY

KW - ANTIINFLAMMATORY AGENTS

KW - CELLULAR UPTAKE

KW - WARM ISCHEMIA

KW - DEATH DONORS

KW - BRAIN-DEATH

KW - TRANSPLANTATION

U2 - 10.1002/bdd.2108

DO - 10.1002/bdd.2108

M3 - Article

VL - 39

SP - 18

EP - 29

JO - Biopharmaceutics & Drug Disposition

JF - Biopharmaceutics & Drug Disposition

SN - 0142-2782

IS - 1

ER -